311 related articles for article (PubMed ID: 25112469)
1. Clinical significance of HuR expression in human malignancy.
Kotta-Loizou I; Giaginis C; Theocharis S
Med Oncol; 2014 Sep; 31(9):161. PubMed ID: 25112469
[TBL] [Abstract][Full Text] [Related]
2. Hu-antigen receptor (HuR) and cyclooxygenase-2 (COX-2) expression in human non-small-cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival.
Giaginis C; Alexandrou P; Tsoukalas N; Sfiniadakis I; Kavantzas N; Agapitos E; Patsouris E; Theocharis S
Tumour Biol; 2015 Jan; 36(1):315-27. PubMed ID: 25252849
[TBL] [Abstract][Full Text] [Related]
3. High expression of HuR in cytoplasm, but not nuclei, is associated with malignant aggressiveness and prognosis in bladder cancer.
Miyata Y; Watanabe S; Sagara Y; Mitsunari K; Matsuo T; Ohba K; Sakai H
PLoS One; 2013; 8(3):e59095. PubMed ID: 23516604
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic expression of the ELAV-like protein HuR as a potential prognostic marker in esophageal squamous cell carcinoma.
Zhang C; Xue G; Bi J; Geng M; Chu H; Guan Y; Wang J; Wang B
Tumour Biol; 2014 Jan; 35(1):73-80. PubMed ID: 23873103
[TBL] [Abstract][Full Text] [Related]
5. Expression of the RNA-binding protein HuR and its clinical significance in human stage I and II lung adenocarcinoma.
Lauriola L; Granone P; Ramella S; Lanza P; Ranelletti FO
Histol Histopathol; 2012 May; 27(5):617-26. PubMed ID: 22419026
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic HuR expression correlates with P-gp, HER-2 positivity, and poor outcome in breast cancer.
Zhu Z; Wang B; Bi J; Zhang C; Guo Y; Chu H; Liang X; Zhong C; Wang J
Tumour Biol; 2013 Aug; 34(4):2299-308. PubMed ID: 23605320
[TBL] [Abstract][Full Text] [Related]
7. Targeting the RNA-Binding Protein HuR in Cancer.
Finan JM; Sutton TL; Dixon DA; Brody JR
Cancer Res; 2023 Nov; 83(21):3507-3516. PubMed ID: 37683260
[TBL] [Abstract][Full Text] [Related]
8. MiR-200c and HuR in ovarian cancer.
Prislei S; Martinelli E; Mariani M; Raspaglio G; Sieber S; Ferrandina G; Shahabi S; Scambia G; Ferlini C
BMC Cancer; 2013 Feb; 13():72. PubMed ID: 23394580
[TBL] [Abstract][Full Text] [Related]
9. The RNA Binding Protein HuR: A Promising Drug Target for Anticancer Therapy.
Wu M; Tong CWS; Yan W; To KKW; Cho WCS
Curr Cancer Drug Targets; 2019; 19(5):382-399. PubMed ID: 30381077
[TBL] [Abstract][Full Text] [Related]
10. Elevated Hu-Antigen Receptor (HuR) Expression is Associated with Tumor Aggressiveness and Poor Prognosis but not with COX-2 Expression in Invasive Breast Carcinoma Patients.
Giaginis C; Sampani A; Kotta-Loizou I; Giannopoulou I; Danas E; Politi E; Tsourouflis G; Kouraklis G; Patsouris E; Keramopoulos A; Nakopoulou L; Theocharis S
Pathol Oncol Res; 2018 Jul; 24(3):631-640. PubMed ID: 28808873
[TBL] [Abstract][Full Text] [Related]
11. Predictive and prognostic significance of cytoplasmic expression of ELAV-like protein HuR in invasive breast cancer treated with neoadjuvant chemotherapy.
Wang J; Li D; Wang B; Wu Y
Breast Cancer Res Treat; 2013 Sep; 141(2):213-24. PubMed ID: 24036660
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of HuR expression in gallbladder carcinoma: with special emphasis on the implications of its nuclear and cytoplasmic expression.
Sun DP; Lin CY; Tian YF; Chen LT; Lin LC; Lee SW; Hsing CH; Lee HH; Shiue YL; Huang HY; Li CF; Liang PI
Tumour Biol; 2013 Oct; 34(5):3059-69. PubMed ID: 23722602
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic HuR expression correlates with angiogenesis, lymphangiogenesis, and poor outcome in lung cancer.
Wang J; Wang B; Bi J; Zhang C
Med Oncol; 2011 Dec; 28 Suppl 1():S577-85. PubMed ID: 21046284
[TBL] [Abstract][Full Text] [Related]
14. The mRNA-stabilizing factor HuR protein is targeted by β-TrCP protein for degradation in response to glycolysis inhibition.
Chu PC; Chuang HC; Kulp SK; Chen CS
J Biol Chem; 2012 Dec; 287(52):43639-50. PubMed ID: 23115237
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Hu-Antigen Receptor (HuR) and Cyclooxygenase-2 (COX-2) Expression in Human Malignant and Benign Thyroid Lesions.
Giaginis C; Alexandrou P; Delladetsima I; Karavokyros I; Danas E; Giagini A; Patsouris E; Theocharis S
Pathol Oncol Res; 2016 Jan; 22(1):189-96. PubMed ID: 26498465
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance and Biological Role of HuR in Head and Neck Carcinomas.
Levidou G; Kotta-Loizou I; Tasoulas J; Papadopoulos T; Theocharis S
Dis Markers; 2018; 2018():4020937. PubMed ID: 29619127
[TBL] [Abstract][Full Text] [Related]
17. Current Evidence and Future Perspectives on HuR and Breast Cancer Development, Prognosis, and Treatment.
Kotta-Loizou I; Vasilopoulos SN; Coutts RH; Theocharis S
Neoplasia; 2016 Nov; 18(11):674-688. PubMed ID: 27764700
[TBL] [Abstract][Full Text] [Related]
18. Hu/elav RNA-binding protein HuR regulates parathyroid hormone related peptide expression in human lung adenocarcinoma cells.
Lauriola L; Serini S; Granone P; Lanza P; Martini M; Calviello G; Ranelletti FO
Histol Histopathol; 2013 Sep; 28(9):1205-16. PubMed ID: 23572284
[TBL] [Abstract][Full Text] [Related]
19. Caspase-mediated cleavage of RNA-binding protein HuR regulates c-Myc protein expression after hypoxic stress.
Talwar S; Jin J; Carroll B; Liu A; Gillespie MB; Palanisamy V
J Biol Chem; 2011 Sep; 286(37):32333-43. PubMed ID: 21795698
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression.
Denkert C; Weichert W; Pest S; Koch I; Licht D; Köbel M; Reles A; Sehouli J; Dietel M; Hauptmann S
Cancer Res; 2004 Jan; 64(1):189-95. PubMed ID: 14729623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
